 |
 |

Nonmelanoma Skin Cancers and Infection With the Human Immunodeficiency Virus
Deborah V. Lobo;
Paul Chu;
Roy C. Grekin, MD;
Timothy G. Berger, MD
Arch Dermatol. 1992;128(5):623-627.
Abstract
 |  |
Background and Design.— Forty-eight human immunodeficiency virus-infected patients with nonmelanoma skin cancers seen during a four-year period were evaluated in a retrospective, case-control study. Patients were followed up after therapy and recurrence rates were determined.
Results.— One hundred and sixteen nonmelanoma skin cancers were identified, 101 of which were basal cell carcinomas (87%), mostly superficial multicentric (67%) of the trunk (62%). There were 15 low-grade squamous cell carcinomas, most commonly of the head and neck. Half of the patients had multiple cancers. Compared with age-matched controls, the patients with skin cancer more commonly had blue/hazel eyes (89% vs 66%; odds ratio [OR] 4.1; confidence interval [CI], 1.25 to 13.44; P =.033), blond hair (42% vs 13%; OR = 4.53; CI, 1.40 to 13.74, P =.003), a family history of skin cancer (45% vs 5%; OR = 11.88; CI, 2.85 to 49.57; P =.00), and a history of regular sunbathing (92% vs 48%; OR = 11.24; CI, 3.17 to 39.83; P =.00). The number of cancers or the presence of squamous cell carcinoma did not correlate with the degree of immunosuppression. The recurrence rate for basal cell carcinomas following standard treatment methods (mostly curettage and electrodesiccation and excision) was 5.4% for those tumors followed up for longer than 12 months. Three of the 15 squamous cell carcinomas recurred, all following curettage and electrodesiccation.
Conclusion.— Nonmelanoma skin cancers are a not uncommon cutaneous finding in human immunodeficiency virus-infected patients. The major risk factors for developing skin cancer in association with human immunodeficiency virus disease seem to be the same as in the normal population—fair skin, a positive family history, and sun exposure. Standard treatment methods seem to be associated with acceptable cure rates, except for squamous cell carcinomas, which had a high (20%) recurrence rate following curettage and electrodesiccation.
(Arch Dermatol. 1992;128:623-627)
Author Affiliations
From the Department of Dermatology, University of California, San Francisco (Drs Lobo, Chu, Grekin, and Berger); and the Department of Dermatology, San Francisco General Hospital (Dr Berger).
Footnotes
Accepted for publication October 28, 1991.
Reprint requests to the Department of Dermatology, 4M70, San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110 (Dr Berger).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cutaneous Malignancies Among HIV-Infected Persons
Crum-Cianflone et al.
Arch Intern Med 2009;169:1130-1138.
ABSTRACT
| FULL TEXT
Aggressive Squamous Cell Carcinomas in Persons Infected With the Human Immunodeficiency Virus
Nguyen et al.
Arch Dermatol 2002;138:758-763.
ABSTRACT
| FULL TEXT
Altered Clinical Course of Malignant Melanoma in HIV-Positive Patients
Rodrigues et al.
Arch Dermatol 2002;138:765-770.
ABSTRACT
| FULL TEXT
Cancer Incidence in New York State Acquired Immunodeficiency Syndrome Patients
Gallagher et al.
Am J Epidemiol 2001;154:544-556.
ABSTRACT
| FULL TEXT
Cutaneous Squamous Cell Carcinoma in Human Immunodeficiency Virus-Infected Patients: A Study of Epidemiologic Risk Factors, Human Papillomavirus, and p53 Expression
Maurer et al.
Arch Dermatol 1997;133:577-583.
ABSTRACT
HIV-Related Tumors of the Oral Cavity
Ficarra and Eversole
CROBM 1994;5:159-185.
ABSTRACT
| FULL TEXT
|